2024 annual financial data
Axsome Therapeutics 2024 Net margin
Direct answer
Net margin was -74.47%.
Operating income was -280,562,000 USD and net income was -287,216,000 USD.
Operating cash flow was -128,410,000 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 385,693,000 USD
- Operating income
- -280,562,000 USD
- Net income
- -287,216,000 USD
- Operating cash flow
- -128,410,000 USD